BioCon China Expo 2023
6month19day-21Day, lasting for three daysBioCon China Expo 2023The 10th International Biopharmaceutical Conference and Exhibition was successfully held at the Hangzhou International Expo Center. This conference brought together 10,000+Industry peers gather in Hangzhou, BioCon ExpoThe total exhibition area has been expanded to20000On a scale of ㎡, gathering200High-quality exhibitors and featured exhibits from Yuji. Several academicians and authoritiesPILead,200The remaining speakers are heavyweight guest representatives from government regulatory agencies, clinical, research, and industry sectors, who have contributed to15The remaining in-depth discussion forum covers350+Dry goods topic, jointly discussing cutting-edge innovation trends in the biopharmaceutical industry; opening ceremony andBioCon AwardsThe exclusive, authoritative event includes an awarding ceremony, dinner, guided tours for groups, brainstorming sessions, and interactive social games on site.
Frost & SullivanFrost & Sullivan,Frost & Sullivan, hereinafter referred to asBioCon AwardsThe strategic partner of the awarding ceremony, in conjunction with the organizers, jointly released the 'Biopharmaceutical Enterprise Excellence Awards for 2019' and the 'Biotechnology Innovator of the Year with the Highest Investment Value'. Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, was invited to attend the main forum of the conference and serve as the moderator for the roundtable discussion.
Roundtable Forum
At the meeting, Mao Hua served as the host of the roundtable forum, alongside Guo Xinjun, Senior Vice President of Fosun Pharma, and the founder of Yino MicroMedicine.CEOChairman and CEO Zhou Guoying,Hopewell Therapeutics CSO,Editas MedicinefrontVP Kate ZhangGene Therapy CompanyExegenesis BioFounders, Chairman and CEO Wu Zhenhua, together, focused on the inevitable path for domestic biotech products to go global, and discussed how to strategize and make early arrangements.
Partner and Managing Director, Greater China, Frost & Sullivan fattening
Mao Hua said, biotechnology Enterprises need to conduct thorough research on market capacity and related data in overseas regions, choose an outbound model and region based on their own circumstances, and implement localization execution strategies; do a good job in product positioning analysis and market analysis, make strategic layouts for the entire product lifecycle, adhere to long-termism and a global perspective, and build a systematic and international business system.
Fuhong Hanlin Senior Vice President Guo Xinzhen
Founder of Yino MicroMedicine,CEOChairman and Director Zhou Guoying
Hopewell Therapeutics CSO,Editas MedicinefrontVP Kate Zhang
Gene Therapy CompanyExegenesis BioFounder, Chairman, CEO Wu Zhenhua
BioCon AwardsAward Ceremony
"BioCon Awards"yesBioCon China ExpoAn authoritative biomedical award created by the organizing committee. This year,BioCon AwardsComprehensive upgrade, covering a total of seven major categories including upstream and downstream enterprises in the biopharmaceutical industry chain/organization/Individuals strive to establish an authoritative industry award that covers the entire lifecycle of the industry, selecting annual leaders at every stage, commending industry pioneers, and creating an industry atmosphere and environment that is proactive, innovative, and forward-looking in the biopharmaceutical industry.
Frost & Sullivan asBioCon AwardsThe strategic partner of the award ceremony, in collaboration with the organizers, released the 'Annual Outstanding Achievements Star in Biopharmaceutical Enterprises' list and the 'Annual Most Investment-Valuable Biotechnology Rising Star' list.
Outstanding
Annual Outstanding Achievements Star in Biopharmaceutical Enterprises
Presenting Guests: Shao Yuanchang, former First-Class Inspector of the Zhejiang Provincial Drug Administration and President of the Zhejiang Pharmaceutical Association
Award-winning organization:
Aimeijie Vaccines Co., Ltd.
Baitai Biopharmaceutical Co., Ltd.
Baida Pharmaceutical Co., Ltd.
Shanghai Fuhong Hanlin Biotechnology Co., Ltd.
limitless
The Most Investment-worthy Biotech Rising Star of the Year
Presenting Guests: Tang Dajie, Chairman of Shenzhen Qianhai Qinzhi International Capital Management Co., Ltd.
Award-winning organization:
Wuhan Ruijian Medical Technology Co., Ltd.
Beijing Zhidao Biotechnology Co., Ltd.
Shanghai Huayao Tai Biopharmaceutical Co., Ltd.
Korontar Biopharmaceutical Co., Ltd.
Nanjing Reindeer Biotechnology Co., Ltd.
Saiyuan Biotechnology (Hangzhou) Co., Ltd.
Shanghai Bangyao Biotechnology Co., Ltd.
Shenzhen Yino Micro Medicine Technology Co., Ltd.
Zhejiang Haichang Biomedical Technology Co., Ltd.
Beijing Chengnuo Medical Technology Co., Ltd.
